FluMist bests traditional shot for kids

Published



Children who are given the FluMist nasal vaccine are 55 percent less likely to succumb to the flu than those who get the shot, according to a study in the New England Journal of Medicine today.

Funded by Gaithersburg?s MedImmune ? the maker of FluMist ? the St. Louis University study enlisted 8,475 children ages 6 months to 5 years in 16 countries.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.